Close
4

Seqens Seqens

X

Company profile for Mebias Discovery

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
MEBIAS holds a game-changing platform to discover next generation, pathway-selective GPCR drugs devoid of on-target side effects once thought to be unavoidable. G-protein Coupled Receptor (GPCR) therapeutics comprise ~30% of current prescribed drugs. By developing pathway-selective/biased drugs within well-understood mechanisms, the significant on-target adverse effects can be alleviated. Cell-based assays alone are inadequate...
MEBIAS holds a game-changing platform to discover next generation, pathway-selective GPCR drugs devoid of on-target side effects once thought to be unavoidable. G-protein Coupled Receptor (GPCR) therapeutics comprise ~30% of current prescribed drugs. By developing pathway-selective/biased drugs within well-understood mechanisms, the significant on-target adverse effects can be alleviated. Cell-based assays alone are inadequate to identify biased drugs. Mebias’ understanding of protein dynamics of GPCRs offers a unique advantage.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Mebias Discovery
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
3001 Market Street, Suite 140, Philadelphia, PA 19104
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY